India Market Report Suite for Vascular Access Devices and Accessories 2017 - MedSuite

 Published On: Jan, 2017 |    No of Pages: 610 |  Published By: iData Research Inc | Format: PDF
Request Free Sample
General Report Contents

• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends

• Market Drivers & Limiters for each chapter segment

• Competitive Analysis for each chapter segment

• Section on recent mergers & acquisitions

In India, health policy is undergoing extensive reform. The government has been particularly interested in ensuring that basic medical services are available for the whole Indian population and not just for the middle and upper class. According to the World Bank and National Commission's report on Macroeconomics, only 5% of Indians are covered by health insurance policies, which is only available for the urban, middle and high income populations. In addition to healthcare reforms, the government is encouraging private capital investment to improve service quality and meet the public's diverse and complex needs. More reform is required to bring new opportunities to invest in the healthcare market and bring profound change to the healthcare landscape in India. In India, the use of central venous catheters (CVCs) have been experiencing tremendous growth over the past several years due to the rise in the number of seriously ill patients and more complex treatment regimens that require the use of CVCs. Despite the fact that peripherally inserted central catheters (PICCs) are associated with lower infections, and in countries such as Australia the use of PICCs has grown significantly at the expense of CVCs, practitioners in India prefer to use CVCs due to its ease of use and low price.

The Indian market for vascular access devices and accessories includes implantable ports, port needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs), and dialysis catheters. The Indian market is still undergoing frequent and drastic changes in terms of regulations, shaped by efforts to contain the growing healthcare budget and supporting market growth and development. Recently, the government has been adamant on clearing regulatory hurdles related to imports and exports of medical devices, and has set new standards around clinical trials. In addition, the Indian government runs several health insurance programs designed for high-risk patients to pay upfront cash and then get reimbursed by filing a claim. This process has proven inefficient and slow, and major improvements are possible if better payment mechanisms are implemented.
TABLE OF CONTENTS I
LIST OF FIGURES XXIX
LIST OF CHARTS XXXIX
EXECUTIVE SUMMARY 1
INDIA VASCULAR ACCESS DEVICE AND ACCESSORIES MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 6
MARKET DEVELOPMENTS 7
MARKETS INCLUDED 8
KEY REPORT UPDATES 9
VERSION HISTORY 9
RESEARCH METHODOLOGY 10
1.1 RESEARCH SCOPE 10
1.2 IDATA'S 9-STEP METHODOLOGY 10
Step 1: Project Initiation & Team Selection 10
Step 2: Prepare Data Systems and Perform Secondary Research 12
Step 3: Preparation for Interviews & Questionnaire Design 13
Step 4: Performing Primary Research 14
Step 5: Research Analysis: Establishing Baseline Estimates 16
Step 6: Market Forecast and Analysis 17
Step 7: Identify Strategic Opportunities 19
Step 8: Final Review and Market Release 20
Step 9: Customer Feedback and Market Monitoring 21

DISEASE OVERVIEW 22
2.1 BASIC ANATOMY 22
2.1.1 Human Vascular System 22
2.2 VASCULAR PATHOLOGY AND DISORDERS 23
2.2.1 Cancer 23
2.2.2 End-Stage Renal Disease 24
2.2.3 Diabetes 26
PRODUCT ASSESSMENT 29
INDIA VASCULAR ACCESS DEVICE AND ACCESSORIES MARKET OVERVIEW 200
4.1 INTRODUCTION 200
4.2 CURRENCY EXCHANGE RATE 201
4.3 MARKET OVERVIEW 202
4.4 TREND ANALYSIS BY SEGMENT 208
4.5 DRIVERS AND LIMITERS 211
4.5.1 Market Drivers 211
4.5.2 Market Limiters 212
4.6 COMPETITIVE MARKET SHARE ANALYSIS 214
IMPLANTABLE PORT MARKET 219
5.1 MARKET OVERVIEW 219
5.2 MARKET ANALYSIS AND FORECAST 223
5.2.1 Total Implantable Port Market 223
5.2.2 Conventional Implantable Port Market 225
5.2.3 Power-Injectable Implantable Port Market 227
5.3 DRIVERS AND LIMITERS 229
5.3.1 Market Drivers 229
5.3.2 Market Limiters 229
5.4 COMPETITIVE MARKET SHARE ANALYSIS 231
PORT NEEDLE MARKET 233
6.1 MARKET OVERVIEW 233
6.2 MARKET ANALYSIS AND FORECAST 236
6.2.1 Total Port Needle Market 236
6.2.2 Conventional Implantable Port Market 238
6.2.3 Safety Port Needle Market 240
6.3 DRIVERS AND LIMITERS 242
6.3.1 Market Drivers 242
6.3.2 Market Limiters 243
6.4 COMPETITIVE MARKET SHARE ANALYSIS 245
CENTRAL VENOUS CATHETER MARKET 247
7.1 MARKET OVERVIEW 247
7.2 MARKET ANALYSIS AND FORECAST 251
7.2.1 Total Central Venous Catheter Market 251
7.2.2 Total Acute Central Venous Catheter Market 253
7.2.2.1 Conventional Acute Central Venous Catheter Market 256
7.2.2.2 Antimicrobial Acute CVC Market 258
7.2.3 Chronic Central Venous Catheter Market 260
7.3 DRIVERS AND LIMITERS 262
7.3.1 Market Drivers 262
7.3.2 Market Limiters 263
7.4 COMPETITIVE MARKET SHARE ANALYSIS 265
PERIPHERALLY INSERTED CENTRAL CATHETER MARKET 268
8.1 MARKET OVERVIEW 268
8.2 MARKET ANALYSIS AND FORECAST 272
8.2.1 Total Peripherally Inserted Central Catheter Market 272
8.2.2 Conventional Peripherally Inserted Central Catheter Market 274
8.2.3 Power-Injectable Peripherally Inserted Central Catheter Market 276
8.3 DRIVERS AND LIMITERS 278
8.3.1 Market Drivers 278
8.3.2 Market Limiters 279
8.4 COMPETITIVE MARKET SHARE ANALYSIS 281
PERIPHERAL INTRAVENOUS CATHETER MARKET 284
9.1 MARKET OVERVIEW 284
9.2 MARKET ANALYSIS AND FORECAST 288
9.2.1 Total Peripheral Intravenous Venous Catheter Market 288
9.2.2 Conventional Peripheral Intravenous Venous Catheter Market 290
9.2.3 Safety Peripheral Intravenous Venous Catheter Market 292
9.3 DRIVERS AND LIMITERS 294
9.3.1 Market Drivers 294
9.3.2 Market Limiters 295
9.4 COMPETITIVE MARKET SHARE ANALYSIS 297
DIALYSIS CATHETER MARKET 300
10.1 MARKET ANALYSIS AND FORECAST 300
10.2 DRIVERS AND LIMITERS 302
10.2.1 Market Drivers 302
10.2.2 Market Limiters 303
10.3 COMPETITIVE MARKET SHARE ANALYSIS 305
ABBREVIATIONS 308
APPENDIX: COMPANY PRESS RELEASES 309

LIST OF CHARTS
Chart 1 1: Vascular Access Device and Accessories Market by Segment, India, 2013 - 2023 2
Chart 1 2: Vascular Access Device and Accessories Market by Segment, India, 2016 & 2023 3
Chart 3 1: Central Venous Catheter Market Segments, 2015 42
Chart 4 1: Vascular Access Device and Accessories Market by Segment, India, 2013 - 2023 206
Chart 4 2: Vascular Access Device and Accessories Market Breakdown, India, 2016 207
Chart 4 3: Vascular Access Device and Accessories Market Breakdown, India, 2023 207
Chart 4 4: Growth Rates by Segment, Vascular Access Device and Accessories Market India, 2013 - 2023 210
Chart 4 5: Leading Competitors, Vascular Access Device and Accessories Market, India, 2016 218
Chart 5 1: Implantable Port Market by Segment, India, 2013 - 2023 221
Chart 5 2: Implantable Port Market Breakdown, India, 2016 222
Chart 5 3: Implantable Port Market Breakdown, India, 2023 222
Chart 5 4: Total Implantable Port Market, India, 2013 - 2023 224
Chart 5 5: Conventional Implantable Port Market, India, 2013 - 2023 226
Chart 5 6: Power-Injectable Implantable Port Market, India, 2013 - 2023 228
Chart 5 7: Leading Competitors, Implantable Port Market, India, 2016 232
Chart 6 1: Port Needle Market by Segment, India, 2013 - 2023 234
Chart 6 2: Port Needle Market Breakdown, India, 2016 235
Chart 6 3: Port Needle Market Breakdown, India, 2023 235
Chart 6 4: Total Port Needle Market, India, 2013 - 2023 237
Chart 6 5: Conventional Port Needle Market, India, 2013 - 2023 239
Chart 6 6: Safety Port Needle Market, India, 2013 - 2023 241
Chart 6 7: Leading Competitors, Port Needle Market, India, 2016 246
Chart 7 1: Central Venous Catheter Market by Segment, India, 2013 - 2023 249
Chart 7 2: Central Venous Catheter Market Breakdown, India, 2016 250
Chart 7 3: Central Venous Catheter Market Breakdown, India, 2023 250
Chart 7 4: Total Central Venous Catheter Market, India, 2013 - 2023 252
Chart 7 5: Total Acute Central Venous Catheter Market, India, 2013 - 2023 255
Chart 7 6: Conventional Acute Central Venous Catheter Market, India, 2013 - 2023 257
Chart 7 7: Antimicrobial Acute Central Venous Catheter Market, India, 2013 - 2023 259
Chart 7 8: Chronic Central Venous Catheter Market, India, 2013 - 2023 261
Chart 7 9: Leading Competitors, Central Venous Catheter Market, India, 2016 267
Chart 8 1: Peripherally Inserted Central Catheter Market by Segment, India, 2013 - 2023 270
Chart 8 2: Peripherally Inserted Central Catheter Market Breakdown, India, 2016 271
Chart 8 3: Peripherally Inserted Central Catheter Market Breakdown, India, 2023 271
Chart 8 4: Total Peripherally Inserted Central Catheter Market, India, 2013 - 2023 273
Chart 8 5: Conventional Peripherally Inserted Central Catheter Market, India, 2013 - 2023 275
Chart 8 6: Power-Injectable Peripherally Inserted Central Catheter Market, India, 2013 - 2023 277
Chart 8 7: Leading Competitors, Peripherally Inserted Central Catheter Market, India, 2016 283
Chart 9 1: Peripheral Intravenous Venous Catheter Market by Segment, India, 2013 - 2023 286
Chart 9 2: Peripheral Intravenous Venous Catheter Market Breakdown, India, 2016 287
Chart 9 3: Peripheral Intravenous Venous Catheter Market Breakdown, India, 2023 287
Chart 9 4: Total Peripheral Intravenous Venous Catheter Market, India, 2013 - 2023 289
Chart 9 5: Conventional Peripheral Intravenous Venous Catheter Market, India, 2013 - 2023 291
Chart 9 6: Safety Peripheral Intravenous Venous Catheter Market, India, 2013 - 2023 293
Chart 9 7: Leading Competitors, Peripheral Intravenous Venous Catheter Market, India, 2016 299
Chart 10 1: Total Dialysis Catheter Market, India, 2013 - 2023 301
Chart 10 2: Leading Competitors, Dialysis Catheter Market, India, 2016 307

LIST OF FIGURES
Figure 1 1: Vascular Access Device and Accessories Market by Segment India, 2016 (1 of 2) 4
Figure 1 2: Vascular Access Device and Accessories Market by Segment India, 2016 (2 of 2) 4
Figure 1 3: Companies Researched in this Report, India, 2016 5
Figure 1 4: Factors Impacting the Vascular Access Device and Accessories Market by Segment, India 6
Figure 1 5: Recent Events in the Vascular Access Device and Accessories MarketIndia, 2012 - 2016 7
Figure 1 6: Vascular Access Device and Accessories Markets Covered, India, 2016 8
Figure 1 7: Key Report Updates 9
Figure 1 8: Version History 9
Figure 3 1: Class 2 Device Recall Medtronic 99
Figure 3 2: Class 2 Device Recall Smiths Medical 99
Figure 3 3: Class 2 Device Recall Arrow 100
Figure 3 4: Class 2 Device Recall Arrow 100
Figure 3 5: Class 2 Device Recall Covidien (Medtronic) 101
Figure 3 6: Class 2 Device Recall Arrow 102
Figure 3 7: Class 2 Device Recall Medline 102
Figure 3 8: Class 2 Device Recall Arrow 102
Figure 3 9: Class 2 Device Recall B. Braun 102
Figure 3 10: Class 3 Device Recall Bard Access 103
Figure 3 11: Class 2 Device Recall Covidien (Medtronic) 103
Figure 3 12: Class 2 Device Recall Bard Access 105
Figure 3 13: Class 2 Device Recall Bard Access 105
Figure 3 14: Class 2 Device Recall Medcomp & AngioDynamics 106
Figure 3 15: Class 2 Device Recall Bard Access 106
Figure 3 16: Class 2 Device Recall Arrow 107
Figure 3 17: Class 2 Device Recall Medcomp 107
Figure 3 18: Class 2 Device Recall Arrow 107
Figure 3 19: Class 2 Device Recall Arrow 108
Figure 3 20: Class 2 Device Recall Smiths Medical 108
Figure 3 21: Class 2 Device Recall PFM Medical 108
Figure 3 22: Class 2 Device Recall PFM Medical 108
Figure 3 23: Class 2 Device Recall Becton Dickinson 109
Figure 3 24: Class 2 Device Recall Arrow 109
Figure 3 25: Class 2 Device Recall Arrow 109
Figure 3 26: Class 2 Device Recall Navilyst Medical 109
Figure 3 27: Class 2 Device Recall Argon Medical 110
Figure 3 28: Class 2 Device Recall Arrow 111
Figure 3 29: Class 2 Device Recall Arrow 111
Figure 3 30: Class 2 Device Recall Arrow 112
Figure 3 31: Class 2 Device Recall Bard Access 112
Figure 3 32: Class 2 Device Recall Navilyst Medical 112
Figure 3 33: Class 2 Device Recall Bard Access 113
Figure 3 34: Class 2 Device Recall Smiths Medical 113
Figure 3 35: Class 2 Device Recall B. Braun 113
Figure 3 36: Class 2 Device Recall Smiths Medical 114
Figure 3 37: Class 2 Device Recall Access Scientific 114
Figure 3 38: Class 2 Device Recall Covidien (Medtronic) 114
Figure 3 39: Class 2 Device Recall Arrow 115
Figure 3 40: Class 2 Device Recall Bard Access 115
Figure 3 41: Class 2 Device Recall Becton Dickinson 115
Figure 3 42: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 116
Figure 3 43: Class 2 Device Recall Bard Access 116
Figure 3 44: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 116
Figure 3 45: Class 2 Device Recall Medcomp 117
Figure 3 46: Class 2 Device Recall Becton Dickinson 117
Figure 3 47: Class 3 Device Recall Bard Access 117
Figure 3 48: Class 2 Device Recall Medcomp 118
Figure 3 49: Class 1 Device Recall Arrow 118
Figure 3 50: Class 2 Device Recall Arrow 118
Figure 3 51: Class 2 Device Recall Vygon 118
Figure 3 52: Class 2 Device Recall Covidien (Medtronic) 119
Figure 3 53: Class 2 Device Recall Medcomp 120
Figure 3 54: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 120
Figure 3 55: Class 2 Device Recall Christie Medical Holdings 120
Figure 3 56: Class 3 Recall Bard Access 120
Figure 3 57: Class 2 Device Recall AngioDynamics 121
Figure 3 58: Class 2 Device Recall Becton Dickinson 121
Figure 3 59: Class 2 Device Recall AngioDynamics 121
Figure 3 60: Class 2 Device Recall AngioDynamics 123
Figure 3 61: Class 3 Device Recall AngioDynamics 124
Figure 3 62: Class 2 Device Recall AngioDynamics 124
Figure 3 63: Bone Anchored Port - a Novel Vascular Access for Hemodialysis Treatment 126
Figure 3 64: A Pragmatic Randomized Trial 126
Figure 3 65: Assessment of a Power Injectable vs. a Non-Power Injectable 127
Figure 3 66: Vascular Access in Cancer Patients 127
Figure 3 67: Ultrasound-guided Subclavian Vein Puncture Versus Cephalic Vein Dissection 127
Figure 3 68: Central Line Placement Study 128
Figure 3 69: The Effects of Anti-infective Central Venous Catheter (CVC) 128
Figure 3 70: The Use of Point of Care Ultra Sound 129
Figure 3 71: Complications Associated With Central Venous Access 129
Figure 3 72: Impact of Ultrasound Guided Central Venous Catheterization 130
Figure 3 73: Randomized, Prospective, Single-center Study 130
Figure 3 74: Remifentanil and Local Anesthesia 131
Figure 3 75: Dissemination of a Simulation-based Mastery Learning Curriculum 131
Figure 3 76: Incidence of Complication 132
Figure 3 77: Comparison of Two Needle Insertion Techniques 132
Figure 3 78: A Monocenter Prospective Study 133
Figure 3 79: A Prospective Study to Compare Point of Care Echocardiography Versus Chest Radiography 133
Figure 3 80: Long-versus Short-Axis Ultrasound Guidance for Subclavian Vein Cannulation 134
Figure 3 81: Use of Chlorhexidine-gel-Impregnated Dressing Compared to Transparent Polyurethane Film Dressing 134
Figure 3 82: Vascular Access in Hematological Patients 135
Figure 3 83: Developing and Maintaining a Central Venous Catheter Registry 135
Figure 3 84: Reliability of Central Venous Pressure Measurements 135
Figure 3 85: SUBclavian Central Venous Catheters Guidance and Examination by UltraSound 136
Figure 3 86: Chlorhexidine Containing IV-securement Dressings 136
Figure 3 87: Comparison of Effectiveness and Safety of Two Methods for Installing Femoral Central Venous Catheters 137
Figure 3 88: A Phase III Study of Peripherally Inserted Versus Centrally Inserted Central Venous Catheters 137
Figure 3 89: Ultrasound Guided Diagnosis of Central Venous Catheters in Children 138
Figure 3 90: Real-time Ultrasound-guided Catheterization of the Axillary Vein in the Intensive Care Unit 138
Figure 3 91: Determination of Anatomic Variations of the Internal Jugular and Femoral Veins 139
Figure 3 92: Comparison of Subclavian, Femoral and Internal Jugular Venous Catheterization 139
Figure 3 93: Landmark vs. Ultrasound Guided Subclavian Central Venous Catheter Placement 140
Figure 3 94: Interest of Ultrasound Coupled to a Guidance System (GPS) 140
Figure 3 95: Risk of Central Venous Stenosis in Patients With Chronic Renal Failure After IJ Line Placement 141
Figure 3 96: Comparison of the Central Venous Catheter Insertion Techniques 141
Figure 3 97: A Multicenter, Open-label, Randomised, Clinical Trial 142
Figure 3 98: A Pragmatic Randomized Trial Standard of Care Vascular Access Strategies 142
Figure 3 99: PICC and Midline Related Complications: A Multicenter Observational Study 143
Figure 3 100: Complications Associated With Central Venous Access 143
Figure 3 101: Evaluation of Electrocardiographic Guidance 143
Figure 3 102: Phase II Randomised Study Comparing the Tolerance of PICC Line 144
Figure 3 103: Randomized, Prospective, Single-center Study 144
Figure 3 104: A Randomized Controlled Trial Comparing Ultrasound Guided PICC Line Insertion 145
Figure 3 105: Ultrasound-guided Peripheral Vascular Access 145
Figure 3 106: Vascular Access in Cancer Patients 146
Figure 3 107: A Monocenter Prospective Study 147
Figure 3 108: Vascular Access in Hematological Patients 147
Figure 3 109: ECG Versus Ultrasound-guided Positioning of the Peripherally Inserted Central Catheter (PICC) Tip 147
Figure 3 110: Sequential Pneumatic Compression 148
Figure 3 111: Reliability of Central Venous Pressure Measurements 148
Figure 3 112: Time and Motion Related to PICC Insertion Process and Catheter Tip Confirmation 149
Figure 3 113: A Randomized Open-labeled Multicenter Study 149
Figure 3 114: A Phase III Study of Peripherally Inserted Versus Centrally Inserted Central Venous Catheters 150
Figure 3 115: A Randomized Prospective Multicenter Evaluation 150
Figure 3 116: Randomized Double Blind Comparison 151
Figure 3 117: An Observational, Prospective, Single-center Study of Placement and Confirmation 151
Figure 3 118: PICC and Midline Related Complications 152
Figure 3 119: Contribution of Ultrasound for Peripheral Intravenous Catheter Placement by Intensive Care Nurses 152
Figure 3 120: A Comparison of Accuvein to Standard Intravenous Access 153
Figure 3 121: Randomized, Controlled Study of Ultrasound-Guided Peripheral Venous Access 153
Figure 3 122: Pen Torch Transillumination: Shedding Light on Difficult Venepuncture 154
Figure 3 123: Ultrasound-guided Peripheral Vascular Access in Children 154
Figure 3 124: Preventing Delay of Care in Patient With Difficult IV Access 155
Figure 3 125: A Randomized Control Trial of Ultrasound Guided IV Access 155
Figure 3 126: Removal Peripheral Intravenous Catheters According to Clinical Signs 156
Figure 3 127: Clinical Investigation Acc. to MPG §23b 156
Figure 3 128: Evaluation of Accuvein® in Obese Patients 156
Figure 3 129: A Randomized, Open Label Study to Evaluate the Effectiveness of the MMT Initial Specimen Diversion Device 157
Figure 3 130: Technique for Successful Ultrasound-guided Peripheral Vascular Access 157
Figure 3 131: A Randomized Controlled Open Label Trial 157
Figure 3 132: A Prospective Feasibility Trial of AccuCath® 2.25" BC Intravascular Catheter System 158
Figure 3 133: The Use of a Topical Anesthetic Skin Refrigerant 158
Figure 3 134: A Randomized Controlled Trial to Demonstrate the Safety and Efficacy of the OptiVein® IV Catheter 159
Figure 3 135: Observational Study of the Sonic Window™ Handheld Ultrasound System 159
Figure 3 136: Near-Infrared Software Performance Study 159
Figure 3 137: A Randomized Controlled Trial To Compare The Initial Success Rate 160
Figure 3 138: A Clinical Assessment of an Ultrasound-guided Inserted Peripheral Intravenous Catheter 160
Figure 3 139: Ultrasound Guided Peripheral Intravenous Catheter Insertion 160
Figure 3 140: Nurse Peripheral Intravenous Catheter Insertion Success 161
Figure 3 141: ACCESS HD Pilot 161
Figure 3 142: Randomized Controlled Trial of Straight Versus Coiled Peritoneal Dialysis 162
Figure 3 143: Randomized Trial Comparing VectorFlow™ Tunneled Dialysis Catheter 162
Figure 3 144: Duration and Adverse Events of Non-cuffed Catheter 162
Figure 3 145: Vascular Access Choice and Outcomes in the Elderly and Very Elderly 163
Figure 3 146: Prevention of Tunneled Cuffed Catheter Malfunction 163
Figure 3 147: Analysis of CRBSI 164
Figure 3 148: A Prospective Multicenter Investigation 164
Figure 3 149: Comparison of an Intensive Versus a Standard Hemodialysis Central Venous Catheter 164
Figure 3 150: Post Marketing Surveillance of the CentrosFLO™ Tunneled IJ Catheter for Dialysis 165
Figure 3 151: Comparison of Self-locating Catheter Versus a Straight Catheter for Outflow Problems 165
Figure 3 152: Multi-Center, Prospective, Randomized, Open-Label, Sponsor-Blinded, Active-Control (Heparin) Clinical Investigation 166
Figure 3 153: Comparative Effectiveness of 30% Trisodium Citrate and Heparin Lock Solutions 166
Figure 3 154: The Use of Point of Care Ultra Sound for Correct Placement 167
Figure 3 155: Contribution of Ultrasound for Peripheral Intravenous Catheter 167
Figure 3 156: Evaluation of Electrocardiographic Guidance 168
Figure 3 157: Impact of Ultrasound Guided Central Venous Catheterization 168
Figure 3 158: A Comparison of Accuvein to Standard Intravenous Access 168
Figure 3 159: Randomized, Controlled Study of Ultrasound-Guided Peripheral Venous Access 169
Figure 3 160: Pen Torch Transillumination: Shedding Light on Difficult Venepuncture 169
Figure 3 161: Incidence of Complication Depending on the Cannulation Site 170
Figure 3 162: A Randomized Controlled Trial Comparing Ultrasound Guided PICC Line Insertion 170
Figure 3 163: Ultrasound-guided Peripheral Vascular Access in Children 171
Figure 3 164: Preventing Delay of Care in Patient With Difficult IV Access 171
Figure 3 165: Ultrasound-guided Peripheral Vascular Access 172
Figure 3 166: A Randomized Control Trial of Ultrasound Guided IV Access 172
Figure 3 167: Long-versus Short-Axis Ultrasound Guidance for Subclavian Vein Cannulation 173
Figure 3 168: A Prospective Study to Compare Point of Care Echocardiography Versus Chest Radiography 173
Figure 3 169: ECG Versus Ultrasound-guided Positioning 173
Figure 3 170: SUBclavian Central Venous Catheters Guidance and Examination 174
Figure 3 171: Evaluation of Accuvein® in Obese Patients 174
Figure 3 172: Time and Motion Related to PICC Insertion Process 175
Figure 3 173: Technique for Successful Ultrasound-guided Peripheral Vascular Access 175
Figure 3 174: A Randomized Open-labeled Multicenter Study 176
Figure 3 175: Comparison of Effectiveness and Safety of Two Methods for Installing Femoral Central Venous Catheters 176
Figure 3 176: Ultrasound Guided Diagnosis of Central Venous Catheters in Children 177
Figure 3 177: Real-time Ultrasound-guided Catheterization of the Axillary Vein 177
Figure 3 178: Observational Study of the Sonic Window™ Handheld Ultrasound System 178
Figure 3 179: Ultrasound-guided Subclavian Vein Puncture 178
Figure 3 180: Near-Infrared Software Performance Study 178
Figure 3 181: Landmark vs. Ultrasound Guided Subclavian Central Venous Catheter Placement 179
Figure 3 182: Interest of Ultrasound Coupled to a Guidance System (GPS) 179
Figure 3 183: A Randomized Controlled Trial 180
Figure 3 184: A Clinical Assessment of an Ultrasound-guided Inserted Peripheral Intravenous Catheter 180
Figure 3 185: Ultrasound Guided Peripheral Intravenous Catheter Insertion 180
Figure 3 186: An Observational, Prospective, Single-center Study 181
Figure 3 187: Nurse Peripheral Intravenous Catheter Insertion Success 181
Figure 3 188: Unit Based Comparison of Non-Versus Chlorhexidine-Impregnated Central Line Dressings 182
Figure 3 189: Use of Chlorhexidine-gel-Impregnated Dressing 182
Figure 3 190: Comparing SecurAcath® Versus StatLock® 183
Figure 3 191: Chlorhexidine Containing Iv-securement Dressings 183
Figure 3 192: A Randomized, Parallel Design Study 184
Figure 3 193: Pen Torch Transillumination: Shedding Light on Difficult Venepuncture 184
Figure 3 194: Transition From Parenteral Prostanoids to Inhaled Treprostinil 185
Figure 3 195: Efficacy, Safety and Acceptability of the New Pen Needle 185
Figure 3 196: A Phase I Study of the Safety, Reactogenicity, Acceptability and Immunogenicity 186
Figure 3 197: A Single Centre, Randomised, 3-period Cross-over Trial 186
Figure 3 198: A Phase IV, Non-Inferiority, Observer Blind, Randomized Clinical Study 187
Figure 3 199: Treating Diabetic Lipohypertrophy With Intensive Education 187
Figure 3 200: Pharmacokinetic Comparison of Intradermal Versus Sub-cutaneous Insulin 188
Figure 3 201: A Randomized, Multi-centre Cross-over Study 188
Figure 3 202: A Clinical Investigation to Evaluate the Safety and Performance 189
Figure 3 203: A Phase I, Randomized, Open-Label, Parallel-Group, Single-Dose, Multi-Center Study 189
Figure 3 204: Pharmacokinetic and Pharmacodynamic Profile of Insulin Lispro 190
Figure 3 205: Reproducibility of Insulin Action When Administered by Needle-free Jet Injection 190
Figure 3 206: Patient Experiences With Injection Needles 191
Figure 3 207: Inactivated Influenza Via Jet Injection 191
Figure 3 208: Intradermal Rabies Immunization Using NanoJect: A Comparative Study 192
Figure 3 209: Phase 1b, Partial-Blind, Parallel Group, Randomized Study 192
Figure 3 210: A Phase I, Open Label, CT to Evaluate the Safety, Tolerability and Immunogenicity 193
Figure 4 1: Currency Exchange Rate, 2016 201
Figure 4 2: Total Vascular Access Device and Accessories Market, India, 2013 - 2023 (US$M) 203
Figure 4 3: Total Vascular Access Device and Accessories Market, India, 2013 - 2023 (IN?M) 203
Figure 4 4: Vascular Access Device and Accessories Market by Segment, India, 2013 - 2023 (US$M) 204
Figure 4 5: Vascular Access Device and Accessories Market by Segment, India, 2013 - 2023 (IN?M) 205
Figure 4 6: Growth Rates by Segment, Vascular Access Device and Accessories Market, India, 2013 - 2023 (1 of 2) 208
Figure 4 7: Growth Rates by Segment, Vascular Access Device and Accessories Market, India, 2013 - 2023 (2 of 2) 209
Figure 4 8: Drivers and Limiters, Vascular Access Device and Accessories Market, India, 2016 213
Figure 4 9: Leading Competitors, Vascular Access Device and Accessories Market, India, 2016 217
Figure 5 1: Implantable Port Market by Segment, India, 2013 - 2023 (US$M) 220
Figure 5 2: Implantable Port Market by Segment, India, 2013 - 2023 (IN?M) 220
Figure 5 3: Total Implantable Port Market, India, 2013 - 2023 223
Figure 5 4: Conventional Implantable Port Market, India, 2013 - 2023 225
Figure 5 5: Power-Injectable Implantable Port Market, India, 2013 - 2023 227
Figure 5 6: Drivers and Limiters, Implantable Port Market, India, 2016 230
Figure 5 7: Leading Competitors, Implantable Port Market, India, 2016 232
Figure 6 1: Port Needle Market by Segment, India, 2013 - 2023 (US$M) 233
Figure 6 2: Port Needle Market by Segment, India, 2013 - 2023 (IN?M) 234
Figure 6 3: Total Port Needle Market, India, 2013 - 2023 236
Figure 6 4: Conventional Port Needle Market, India, 2013 - 2023 238
Figure 6 5: Safety Port Needle Market, India, 2013 - 2023 240
Figure 6 6: Drivers and Limiters, Port Needle Market, India, 2016 244
Figure 6 7: Leading Competitors, Port Needle Market, India, 2016 246
Figure 7 1: Central Venous Catheter Market by Segment, India, 2013 - 2023 (US$M) 248
Figure 7 2: Central Venous Catheter Market by Segment, India, 2013 - 2023 (IN?M) 248
Figure 7 3: Total Central Venous Catheter Market, India, 2013 - 2023 251
Figure 7 4: Total Acute Central Venous Catheter Market, India, 2013 - 2023 253
Figure 7 5: Total Acute Central Venous Catheter Market by SegmentIndia, 2013 - 2023 (US$M) 254
Figure 7 6: Total Acute Central Venous Catheter Market by SegmentIndia, 2013 - 2023 (IN?M) 254
Figure 7 7: Conventional Acute Central Venous Catheter Market, India, 2013 - 2023 256
Figure 7 8: Antimicrobial Acute Central Venous Catheter Market, India, 2013 - 2023 258
Figure 7 9: Chronic Central Venous Catheter Market, India, 2013 - 2023 260
Figure 7 10: Drivers and Limiters, Central Venous Catheter Market, India, 2016 264
Figure 7 11: Leading Competitors, Central Venous Catheter Market, India, 2016 266
Figure 8 1: Peripherally Inserted Central Catheter Market by Segment, India, 2013 - 2023 (IN?M) 269
Figure 8 2: Peripherally Inserted Central Catheter Market by Segment, India, 2013 - 2023 (IN?M) 269
Figure 8 3: Total Peripherally Inserted Central Catheter Market, India, 2013 - 2023 272
Figure 8 4: Conventional Peripherally Inserted Central Catheter Market, India, 2013 - 2023 274
Figure 8 5: Power-Injectable Peripherally Inserted Central Catheter Market, India, 2013 - 2023 276
Figure 8 6: Drivers and Limiters, Peripherally Inserted Central Catheter Market, India, 2016 280
Figure 8 7: Leading Competitors, Peripherally Inserted Central Catheter Market, India, 2016 282
Figure 9 1: Peripheral Intravenous Venous Catheter Market by Segment, India, 2013 - 2023 (US$M) 285
Figure 9 2: Peripheral Intravenous Venous Catheter Market by Segment, India, 2013 - 2023 (IN?M) 285
Figure 9 3: Total Peripheral Intravenous Venous Catheter Market, India, 2013 - 2023 288
Figure 9 4: Conventional Peripheral Intravenous Venous Catheter Market, India, 2013 - 2023 290
Figure 9 5: Safety Peripheral Intravenous Venous Catheter Market, India, 2013 - 2023 292
Figure 9 6: Drivers and Limiters, Peripheral Intravenous Venous Catheter Market, India, 2016 296
Figure 9 7: Leading Competitors, Peripheral Intravenous Venous Catheter Market, India, 2016 298
Figure 10 1: Total Dialysis Catheter Market, India, 2013 - 2023 301
Figure 10 2: Drivers and Limiters, Dialysis Catheter Market, India, 2016 304
Figure 10 3: Leading Competitors, Dialysis Catheter Market, India, 2016 306
Figure 12 1: Press Release Summary 309

If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.